Product
Doxorubicin + Cisplatin
1 clinical trial
3 indications
Indication
Stomach CancerIndication
Peritoneal MetastasesIndication
Chemotherapy EffectClinical trial
Neoadjuvant Systemic and Peritoneal Chemotherapy for Regionally Advanced Gastric Cancer With Minimal Peritoneal DiseaseStatus: Not yet recruiting, Estimated PCD: 2025-07-01